Vertex Pharmaceuticals (VRTX)

R&D Expense Growth

3.35%

Quarterly · Period ending:

VRTX logo

VRTX R&D Expense Growth

Latest reported3.35%
VRTX Quarterly R&D Growth (QoQ) (0.00% → 3.35%)
High-resolution chart · PNG

VRTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
6.413%
3.8735%
17.7862%
7.6877%
6.5577%
2.7845%
10.3659%
-13.6842%
2.1505%
2.7624%
15.2866%
24.6032%
3.2787%
-12.8571%
-14.6341%
51.8519%
4.8544%
30.3797%
-7.0588%
-10.5263%
2.1505%
10.7143%
-2.3256%
-43.0464%
60.6383%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.